909
Views
15
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Chlorambucil for the treatment of patients with chronic lymphocytic leukemia (CLL) – a systematic review and meta-analysis of randomized trials

, , , , , , & show all
Pages 2047-2057 | Received 25 Nov 2015, Accepted 09 Feb 2016, Published online: 16 Mar 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Carlos Chiattone, David Gomez-Almaguer, Carolina Pavlovsky, Elena J. Tuna-Aguilar, Ana L. Basquiera, Luis Palmer, Danielle Leao Cordeiro de Farias, Sergio Schusterschitz da Silva Araujo, Kenny Mauricio Galvez-Cardenas, Alvaro Gomez Diaz, Jennifer H. Lin, Yen-wen Chen, Gerardo Machnicki, Michelle Mahler, Lori Parisi & Paula Barreyro. (2020) Real-world analysis of treatment patterns and clinical outcomes in patients with newly diagnosed chronic lymphocytic leukemia from seven Latin American countries. Hematology 25:1, pages 366-371.
Read now
Nathan D. Gay, Eliana Kozin, Craig Okada, Alexey V. Danilov & Stephen Spurgeon. (2018) Obinutuzumab monotherapy in previously untreated chronic lymphocytic leukemia. Leukemia & Lymphoma 59:9, pages 2258-2260.
Read now

Articles from other publishers (13)

Maria Chiara Astuto & Catalina Manieu. 2024. Encyclopedia of Toxicology. Encyclopedia of Toxicology 819 823 .
Yang Bai, Xihua Li, Sijie Song, Jing Yang, Xia Liu & Zhaowei Chen. (2023) Pillar[6]arene-based supramolecular self-assemblies for two-pronged GSH-consumption-augmented chemo/photothermal therapy. Nano Research 16:7, pages 9921-9929.
Crossref
Surya K. De. 2023. Medicines for Cancer. Medicines for Cancer 7 159 .
Katarzyna Rakoczy, Wojciech Szlasa, Natalia Sauer, Jolanta Saczko & Julita Kulbacka. (2022) Molecular relation between biological stress and carcinogenesis. Molecular Biology Reports 49:10, pages 9929-9945.
Crossref
Yang Bai, Caiping Liu, Jing Yang, Chengfei Liu, Qingqing Shang & Wei Tian. (2022) Supramolecular self-assemblies based on water-soluble pillar[6]arene and drug-drug conjugates for the combination of chemotherapy. Colloids and Surfaces B: Biointerfaces 217, pages 112606.
Crossref
Yang Bai, Xihua Li, Muqiong Li, Qingqing Shang, Jing Yang, Li Fan & Wei Tian. (2022) Host–guest interaction-based supramolecular prodrug self-assemblies for GSH-consumption augmented chemotherapy. Journal of Materials Chemistry B 10:26, pages 4952-4958.
Crossref
Mofei Huang, Charles R. Myers, Yian Wang & Ming You. (2021) Mitochondria as a Novel Target for Cancer Chemoprevention: Emergence of Mitochondrial-targeting Agents. Cancer Prevention Research 14:3, pages 285-306.
Crossref
Andrea Lenartova, Tom Børge Johannesen & Geir Erland Tjønnfjord. (2020) Chronic lymphocytic leukemia and secondary hematological malignancies: A nation‐wide cancer registry study. European Journal of Haematology 104:6, pages 546-553.
Crossref
Cho-Hao Lee, Yi-Ying Wu, Tzu-Chuan Huang, Chin Lin, Yi-Fen Zou, Ju-Chun Cheng & Ching-Liang Ho. (2019) Maintenance therapy for chronic lymphocytic leukaemia. Cochrane Database of Systematic Reviews.
Crossref
T. M. Ebaston, Alex Rozovsky, Alisa Zaporozhets, Andrii Bazylevich, Helena Tuchinsky, Vered Marks, Gary Gellerman & Leonid D. Patsenker. (2019) Peptide‐Driven Targeted Drug‐Delivery System Comprising Turn‐On Near‐Infrared Fluorescent Xanthene–Cyanine Reporter for Real‐Time Monitoring of Drug Release. ChemMedChem 14:19, pages 1727-1734.
Crossref
Nalin Seixas, Bruno Ravanello, Ibrahim Morgan, Goran Kaluđerović & Ludger Wessjohann. (2019) Chlorambucil Conjugated Ugi Dendrimers with PAMAM-NH2 Core and Evaluation of Their Anticancer Activity. Pharmaceutics 11:2, pages 59.
Crossref
Alexander Egle, Lisa Pleyer, Thomas Melchardt, Tanja Nicole Hartmann & Richard Greil. (2018) Remission maintenance treatment options in chronic lymphocytic leukemia. Cancer Treatment Reviews 70, pages 56-66.
Crossref
Xiu Xiu Peng, Kai Rui Feng & Yu Jie Ren. (2017) Molecular modeling studies of quinazolinone derivatives as novel PI3Kδ selective inhibitors. RSC Advances 7:89, pages 56344-56358.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.